New Born Screening
Newborn screening is the process of testing newborn babies for treatable genetic, endocrinological, metabolic and haematological diseases. They are also known as Inborn Errors of Metabolism (IEM) and these occur when the baby is unable to break down certain naturally produced chemicals which can then build up and lead to slow physical development or brain damage and in some cases, even death.
Parents can pass on the family gene of certain disorders without even knowing that they are carriers.
Newborn screening has been adopted by most countries around the world, though the list of screened diseases varies widely, depending on the prevalence of diseases in that region. In the United States, they routinely screen for around 30 parameters.
The comprehensive Newborn Screening programme that Eastern Innovative offers, screens for 50+ IEM disorders that are curable if detected at an early age.
For more information visit here New Born Screening